933 related articles for article (PubMed ID: 30088015)
21. Left Atrial Appendage Occlusion Device and Novel Oral Anticoagulants Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Briceno DF; Villablanca P; Cyrille N; Massera D; Bader E; Manheimer E; Aagaard P; Ferrick K; Gross J; Kim SG; Krumerman A; Palma E; Guttenplan N; Romero J; Fisher J; Garcia M; Natale A; Di Biase L
Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1057-64. PubMed ID: 26226997
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Safety Outcomes of Oral Antithrombotics for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Network Meta-analysis.
Lin L; Lim WS; Zhou HJ; Khoo AL; Tan KT; Chew AP; Foo D; Chin JJ; Lim BP
J Am Med Dir Assoc; 2015 Dec; 16(12):1103.e1-19. PubMed ID: 26527225
[TBL] [Abstract][Full Text] [Related]
24. Systematic screening for the detection of atrial fibrillation.
Moran PS; Teljeur C; Ryan M; Smith SM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009586. PubMed ID: 27258214
[TBL] [Abstract][Full Text] [Related]
25. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.
Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P
Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948
[TBL] [Abstract][Full Text] [Related]
26. Bleeding of new oral anticoagulants for stroke prevention in atrial fibrillation: a meta-analysis of randomized controlled trials.
Kwong JS; Lam YY; Yan BP; Yu CM
Cardiovasc Drugs Ther; 2013 Feb; 27(1):23-35. PubMed ID: 23224686
[TBL] [Abstract][Full Text] [Related]
27. Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation.
Baker WL; Phung OJ
Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):711-9. PubMed ID: 22912382
[TBL] [Abstract][Full Text] [Related]
28. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Crotty K; Yun JDY; Middleton JC; Feltner C; Taylor-Phillips S; Barclay C; Dotson A; Baker C; Balio CP; Voisin CE; Harris RP
JAMA; 2021 Aug; 326(8):744-760. PubMed ID: 34427595
[TBL] [Abstract][Full Text] [Related]
29. Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis.
Lip GY; Edwards SJ
Thromb Res; 2006; 118(3):321-33. PubMed ID: 16198396
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis.
Savarese G; Giugliano RP; Rosano GM; McMurray J; Magnani G; Filippatos G; Dellegrottaglie S; Lund LH; Trimarco B; Perrone-Filardi P
JACC Heart Fail; 2016 Nov; 4(11):870-880. PubMed ID: 27614940
[TBL] [Abstract][Full Text] [Related]
31. Comparing mortality in patients with atrial fibrillation who are receiving a direct-acting oral anticoagulant or warfarin: a meta-analysis of randomized trials.
Liew A; O'Donnell M; Douketis J
J Thromb Haemost; 2014 Sep; 12(9):1419-24. PubMed ID: 24986568
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
Dentali F; Riva N; Crowther M; Turpie AG; Lip GY; Ageno W
Circulation; 2012 Nov; 126(20):2381-91. PubMed ID: 23071159
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of nonvitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials.
Patti G; Di Gioia G; Cavallari I; Nenna A
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 28029216
[TBL] [Abstract][Full Text] [Related]
34. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
[TBL] [Abstract][Full Text] [Related]
35. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J
JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018
[TBL] [Abstract][Full Text] [Related]
36. Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis.
Melkonian M; Jarzebowski W; Pautas E; Siguret V; Belmin J; Lafuente-Lafuente C
J Thromb Haemost; 2017 Jul; 15(7):1500-1510. PubMed ID: 28393461
[TBL] [Abstract][Full Text] [Related]
37. Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lin JS; Bowles EJA; Williams SB; Morrison CC
JAMA; 2017 May; 317(18):1888-1903. PubMed ID: 28492904
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
